» Articles » PMID: 20553065

Cancer in Asia - Incidence Rates Based on Data in Cancer Incidence in Five Continents IX (1998-2002)

Overview
Specialty Oncology
Date 2010 Jun 18
PMID 20553065
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Data from 44 cancer registries in 15 countries in Asia were published in Cancer Incidence in Five Continents Volume IX (CI5 IX). These and findings from 3 other registries were here analysed to provide an overview on the incidence and characteristics of specific cancers by country/region in Asia. Using the collected database, the annual number of cancer cases and the corresponding population numbers divided into six age groups (0-29, 30-39, 40-49, 50-59, 60-69, 70 and more) were extracted and used for incidence estimation. The incidence rates of cancer across Asia vary greatly, with approximately three fold differences in both males and females.

Citing Articles

Disparity in Lung Cancer Screening Among Smokers and Nonsmokers in China: Prospective Cohort Study.

Wang L, Wang Y, Wang F, Gao Y, Fang Z, Gong W JMIR Public Health Surveill. 2023; 9:e43586.

PMID: 36917151 PMC: 10131892. DOI: 10.2196/43586.


The new AJCC/TNM Staging System (VIII ed.) in papillary thyroid cancer: clinical and molecular impact on overall and recurrence free survival.

Sapuppo G, Tavarelli M, Pellegriti G Ann Transl Med. 2020; 8(13):838.

PMID: 32793683 PMC: 7396237. DOI: 10.21037/atm.2020.03.80.


Cytokines expression levels from tissue, plasma or serum as promising clinical biomarkers in adenocarcinoma of the prostate: a systematic review of recent findings.

Singh J, Sohal S, Lim A, Duncan H, Thachil T, De Ieso P Ann Transl Med. 2019; 7(11):245.

PMID: 31317015 PMC: 6603343. DOI: 10.21037/atm.2019.05.31.


Change of HER2 status during disease recurrence predicts good prognosis for primary squamous cell carcinoma of the breast: A case report.

Cao Y, Yue Y, Zhou X, Luo J, Zeng X, Dong J Medicine (Baltimore). 2019; 98(9):e14654.

PMID: 30817587 PMC: 6831174. DOI: 10.1097/MD.0000000000014654.


Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System.

Bai Y, Xu Y, Wu B Gastroenterol Res Pract. 2018; 2017:2816737.

PMID: 29317864 PMC: 5727640. DOI: 10.1155/2017/2816737.